Novo Nordisk to launch GLP-1 injectible diabetes drug in tablet form by February

[ad_1]


The oral medication is being seen as a breakthrough technology that could change the approach and acceptance of the drug for patients in India, which today has the dubious distinction of being the diabetes capital of the world.

[ad_2]

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *